Literature DB >> 12780552

The clinical importance of alloantibody-mediated rejection.

Philip F Halloran.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12780552     DOI： 10.1034/j.1600-6143.2003.00172.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  6 in total

Review 1.  [The discovery of capillary Cd4 in kidney transplantation and the "renaissance" of humoral rejection].

Authors:  Helmut E Feucht
Journal:  Wien Klin Wochenschr       Date:  2006-07       Impact factor: 1.704

Review 2.  Induction therapy in renal transplantation : an overview of current developments.

Authors:  Gaetano Ciancio; George W Burke; Joshua Miller
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Skin Immunity and Tolerance: Focus on Epidermal Keratinocytes Expressing HLA-G.

Authors:  Guillaume Mestrallet; Nathalie Rouas-Freiss; Joel LeMaoult; Nicolas O Fortunel; Michele T Martin
Journal:  Front Immunol       Date:  2021-12-06       Impact factor: 7.561

Review 4.  Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation.

Authors:  Sophia Lionaki; Konstantinos Panagiotellis; Aliki Iniotaki; John N Boletis
Journal:  Clin Dev Immunol       Date:  2013-11-21

5.  Associations between HVEM/LIGHT/BTLA/CD160 polymorphisms and the occurrence of antibody-mediate rejection in renal transplant recipients.

Authors:  Zijie Wang; Ke Wang; Haiwei Yang; Zhijian Han; Jun Tao; Hao Chen; Yuqiu Ge; Miao Guo; Chuanjian Suo; Ji-Fu Wei; Ruoyun Tan; Min Gu
Journal:  Oncotarget       Date:  2017-10-19

6.  Role of de novo DQ donor-specific antibody in antibody-mediated rejection in renal transplant recipient: A case study.

Authors:  Mohit Chowdhry; Manthan Patel; Yogita Thakur; Vandana Sharma
Journal:  Asian J Transfus Sci       Date:  2019-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.